Customers who buy cannabis from “adult use” dispensaries, where no medical certificate is required, commonly report that they use it for pain relief or to help them sleep.
Use of certain antidepressants to treat depression in patients with diabetes is associated with a reduction in mortality, according to a population-based study.
Children with persistently low plasma vitamin D levels at birth and in early childhood have an increased risk of elevated systolic blood pressure later in childhood, research has suggested.
Taking certain antidepressants reduces the efficacy of the opioid medicine tramadol, according to research published in Pharmacotherapy.
Receiving statin treatment for five years or more is associated with a 21% reduced risk of primary glaucoma, research has shown.
Patients with type 2 diabetes mellitus and chronic kidney disease have a lower risk of kidney failure and cardiovascular events if they are treated with canagliflozin, research has confirmed.
Patients who underwent knee replacement who used an app to monitor their analgesic use had better pain control and took fewer opioids post surgery, study results show.
Concerns raised over non-medical alprazolam useSubscription
The benzodiazepine alprazolam is being obtained for non-medical use in the UK, particularly among young people, a survey has found.
Certain individuals at high risk of developing type 1 diabetes mellitis can delay progression to clinical disease by two years or more with a two-week course of teplizumab, according to results of a phase II study.
Vitamin D supplementation is not associated with a reduced risk of major cardiovascular events, a meta-analysis suggests.
People who take methadone use fewer illicit opioids when galantamine is added to their therapy, research shows.
Prednisolone reduces hand osteoarthritis pain Subscription
Patients with hand osteoarthritis experienced improvements in pain and function with low-dose prednisolone treatment, according to a study presented at the European Congress of Rheumatology.
The ketamine-related nasal spray esketamine is effective at relieving the symptoms of treatment-resistant depression, a phase III study has shown.